Doctor profile · Federal record

Dr. Ansley McKenna, APRN

Family Nurse Practitioner (CMS: Nurse Practitioner) · Family Medicine Physician · Topeka, KS

  • NPI 1508456476
  • Accepts Medicare
  • MIPS 82.1 / 100 · 2023
  • 6 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
2921 Sw Wanamaker Dr
Topeka, KS 666145328
(785) 272-6860
fax (785) 272-5839
Mailing address
2200 Sw 6Th Ave Ste B
Topeka, KS 666061707

Credentials & registration

NPPES · NUCC
NPI registered
January 2021 — 5 yrs on file
Profile last updated
March 5, 2021
Year of graduation
2020 — 6 yrs since
Specialty taxonomy
363LF0000X — NUCC code
State licenses (2)
Kansas #53-79841 · Kansas #79841

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1508456476. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
13,747
Distinct HCPCS
10
Medicare allowed
$232,236
HCPCS Description Services Patients Avg allowed
J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg 9,200 39 $2
17003 Destruction of precancer skin growth, 2-14 growths 1,878 311 $5
99213 Established patient office or other outpatient visit, 20-29 minutes 986 612 $71
17000 Destruction of precancer skin growth, 1 growth 579 408 $42
11102 Biopsy of related skin growth, first growth 222 197 $75
99203 New patient office or other outpatient visit, 30-44 minutes 129 129 $88
11103 Biopsy of related skin growth, each additional growth 128 73 $39
11104 Punch biopsy, first skin growth 118 109 $94
99214 Established patient office or other outpatient visit, 30-39 minutes 109 83 $101
17110 Destruction of skin growth, 1-14 growths 79 53 $87

In context: peer comparison

Among 28 peers in Topeka Family Nurse Practitioner, average services per provider: 166. This provider delivers 83× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,780
Transactions
70
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
E.R. Squibb & Sons, L.L.C. 10 $348.61
Regeneron Healthcare Solutions, INC. 8 $267.69
Novartis Pharmaceuticals Corporation 11 $196.36
Abbvie INC. 11 $185.67
Janssen Biotech, INC. 3 $139.29
Lilly USA, LLC 5 $103.87
Ucb, INC. 4 $86.86
Incyte Corporation 4 $83.92
Sun Pharmaceutical Industries INC. 3 $80.02
Kerecis Limited 3 $63.50
Leo Pharma INC. 2 $34.22
Mayne Pharma Commercial LLC 2 $29.32
Organogenesis INC. 1 $27.01
Organon LLC 2 $25.63
Boehringer Ingelheim Pharmaceuticals, INC. 1 $24.20

By nature of payment

Food and Beverage
$1,538
Education
$242

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
561
Patients
280
Total drug cost
$385,643
Drug Type Claims Patients Total cost
Ketoconazole Generic 125 71 $2,861
Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) Brand 120 64 $5,586
Betamethasone Dipropionate Generic 66 40 $5,414
Clobetasol Propionate Generic 48 22 $4,443
Doxycycline Hyclate Generic 40 21 $1,898
Hydrocortisone Generic 40 27 $305
Desonide Generic 30 20 $3,014
Humira(Cf) Pen (Adalimumab) Brand 22 0 $254,757
Triamcinolone Acetonide Generic 20 15 $163
Valacyclovir (Valacyclovir Hcl) Brand 15 0 $257

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Ansley McKenna's medical specialty?
Dr. Ansley McKenna practices Family Nurse Practitioner in Topeka, KS.
Where does Dr. Ansley McKenna practice?
Dr. Ansley McKenna practices at 2921 Sw Wanamaker Dr, Topeka, KS 666145328. Office phone: 7852726860.
What is Dr. Ansley McKenna's NPI?
Dr. Ansley McKenna's National Provider Identifier (NPI) is 1508456476, issued by NPPES.
Does Dr. Ansley McKenna accept Medicare assignment?
Yes. Dr. Ansley McKenna accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Ansley McKenna commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.